NM_001080418.3:c.1107+1447G>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1
The NM_001080418.3(DLGAP3):c.1107+1447G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.404 in 151,932 control chromosomes in the GnomAD database, including 12,468 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.40 ( 12468 hom., cov: 31)
Consequence
DLGAP3
NM_001080418.3 intron
NM_001080418.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.631
Publications
7 publications found
Genes affected
DLGAP3 (HGNC:30368): (DLG associated protein 3) Predicted to enable PDZ domain binding activity; molecular adaptor activity; and scaffold protein binding activity. Predicted to be involved in protein-containing complex assembly and regulation of postsynaptic neurotransmitter receptor activity. Predicted to be located in synapse. Predicted to be part of postsynaptic density. Predicted to be active in several cellular components, including cholinergic synapse; glutamatergic synapse; and neuromuscular junction. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.552 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DLGAP3 | NM_001080418.3 | c.1107+1447G>T | intron_variant | Intron 3 of 11 | ENST00000373347.6 | NP_001073887.1 | ||
| DLGAP3 | XM_011541879.3 | c.1107+1447G>T | intron_variant | Intron 4 of 12 | XP_011540181.1 | |||
| DLGAP3 | XM_047426631.1 | c.1107+1447G>T | intron_variant | Intron 3 of 11 | XP_047282587.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.404 AC: 61341AN: 151814Hom.: 12453 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
61341
AN:
151814
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.404 AC: 61379AN: 151932Hom.: 12468 Cov.: 31 AF XY: 0.403 AC XY: 29894AN XY: 74230 show subpopulations
GnomAD4 genome
AF:
AC:
61379
AN:
151932
Hom.:
Cov.:
31
AF XY:
AC XY:
29894
AN XY:
74230
show subpopulations
African (AFR)
AF:
AC:
14563
AN:
41450
American (AMR)
AF:
AC:
5817
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
1394
AN:
3464
East Asian (EAS)
AF:
AC:
2050
AN:
5144
South Asian (SAS)
AF:
AC:
2749
AN:
4824
European-Finnish (FIN)
AF:
AC:
3696
AN:
10566
Middle Eastern (MID)
AF:
AC:
120
AN:
294
European-Non Finnish (NFE)
AF:
AC:
29760
AN:
67900
Other (OTH)
AF:
AC:
890
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1902
3803
5705
7606
9508
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
598
1196
1794
2392
2990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1698
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.